Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
InnoRehab from Ottignies-Louvain-la-Neuve, company number BE0761446337, closed financial year 2025 with a result of € -98,995 after tax. For that financial year InnoRehab recorded a gross margin of € -37,137 and equity of € 12,297. Compared with financial year 2024, the result moved from € -202,102 to € -98,995. The company made a loss. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.
€ 12,297
▲ € 19,497 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -98,995
▲ 51 % less loss than in 2024
Profit after tax over the fiscal year.
€ 78,527
▲ 6% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -705,249.
People and assets in 2025
€ 47,724
▲ 18% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 77,745
▼ 28% vs 2024
€ 33,957 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 60,082
▲ 30% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 24,442
▲ 74% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -162,734 | € -208,190 | € -145,383 | € -37,137 | ▲ € 108,246 |
| Profit after taxes | € -178,124 | € -233,562 | € -202,102 | € -98,995 | ▲ € 103,107 |
| Equity | € 206,717 | € 197,965 | € -7,200 | € 12,297 | ▲ € 19,497 |
| Total debts | € 234,822 | € 187,357 | € 169,605 | € 163,199 | ▼ 4% |
| Cash | € 358,362 | € 295,159 | € 74,215 | € 78,527 | ▲ 6% |
| Retained profit | € -170,589 | € -404,151 | € -606,253 | € -705,249 | ▼ € 98,996 |
| Bank debt | € 165,744 | € 137,363 | € 108,041 | € 77,745 | ▼ 28% |
| Balance sheet total | € 441,539 | € 385,322 | € 162,405 | € 175,496 | ▲ 8% |
Key figures of InnoRehab, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to InnoRehab?
What happened at InnoRehab in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Cédric Guyot stepped down as director. NBB
- G-VAN stepped down as director. NBB
- Georges André stepped down as director. NBB
- Invest.BW stepped down as director. NBB
- Karin Maquet stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 98,995. Source: NBB ↗
- Cédric Guyot became a director. NBB
- Georges André became a director. NBB
In short
From € 178,124 loss in 2022 to € 98,995 loss in 2025.
Paid € 6 in corporate taxes since 2022.
A new publication or filing at InnoRehab? We notify you, reason included.
Follow InnoRehabDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of B2START comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
InnoRehabThe shares are held by B2START (6.9%).
Directors
According to the 2025 annual accounts
since 2022 · until 2027
Georges André
Director
since 2023 · until 2027
Director · represented by Corinne Estievenart
Also active at: SOCIETE D'ASSAINISSEMENT ET DE RENOVATION DES SITES INDUSTRIELS DU BRABANT WALLON, SYBERMAT, SCALE UP, TCO Service, Made in BW, Whitestone Group, n-Side, CROSSFACTORY +23 more
since 2022 · until 2027
Cédric Guyot
Director
since 2026 · until 2030
since 2022 · until 2027
Shareholders
6.9%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Avenue des Combattants 93a
1340 Ottignies-Louvain-la-Neuve
Veldkapelgaarde 30
1200 Sint-Lambrechts-Woluwe
Active since 18 January 2021
Rue du Pierroux 6
6971 Tenneville
Active since 1 May 2021
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Zoho Mail
Hosting
AS-HOSTINGER, CY
DNS
OVH DNS
Domain
Domain
wheeleo.eu
Registrar
OVH SAS
Website info
Features
Security
Details
- Company number
- 0761.446.337
- VAT number
- BE 0761.446.337
- Registered office
- Avenue des Combattants 93a, 1340 Ottignies-Louvain-la-Neuve
- Names & denominations
- InnoRehab
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 January 2021
- Peppol
- Active · Active since 27 Mar 2026
- Contact
- wheeleo.eu [email protected] +32474133456
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels